696 related articles for article (PubMed ID: 17587554)
1. HPA axis dysfunction in unmedicated major depressive disorder and its normalization by pharmacotherapy correlates with alteration of neural activity in prefrontal cortex and limbic/paralimbic regions.
Aihara M; Ida I; Yuuki N; Oshima A; Kumano H; Takahashi K; Fukuda M; Oriuchi N; Endo K; Matsuda H; Mikuni M
Psychiatry Res; 2007 Aug; 155(3):245-56. PubMed ID: 17587554
[TBL] [Abstract][Full Text] [Related]
2. HPA-axis regulation at in-patient admission is associated with antidepressant therapy outcome in male but not in female depressed patients.
Binder EB; Künzel HE; Nickel T; Kern N; Pfennig A; Majer M; Uhr M; Ising M; Holsboer F
Psychoneuroendocrinology; 2009 Jan; 34(1):99-109. PubMed ID: 18829172
[TBL] [Abstract][Full Text] [Related]
3. Combined dexamethasone/CRF test in remitted outpatients with recurrent major depressive disorder.
Van Den Eede F; Van den Bossche B; Hulstijn W; Sabbe BG; Cosyns P; Claes SJ
J Affect Disord; 2006 Jul; 93(1-3):259-63. PubMed ID: 16677715
[TBL] [Abstract][Full Text] [Related]
4. Differences in the response to the combined DEX-CRH test between PTSD patients with and without co-morbid depressive disorder.
de Kloet C; Vermetten E; Lentjes E; Geuze E; van Pelt J; Manuel R; Heijnen C; Westenberg H
Psychoneuroendocrinology; 2008 Apr; 33(3):313-20. PubMed ID: 18215470
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal neuroendocrine changes assessed by dexamethasone/CRH and growth hormone releasing hormone tests in psychotic depression.
Owashi T; Otsubo T; Oshima A; Nakagome K; Higuchi T; Kamijima K
Psychoneuroendocrinology; 2008 Feb; 33(2):152-61. PubMed ID: 18068306
[TBL] [Abstract][Full Text] [Related]
6. Dex/CRH-test response and sleep in depressed patients and healthy controls with and without vulnerability for affective disorders.
Friess E; Schmid D; Modell S; Brunner H; Lauer CJ; Holsboer F; Ising M
J Psychiatr Res; 2008 Oct; 42(14):1154-62. PubMed ID: 18281062
[TBL] [Abstract][Full Text] [Related]
7. Impaired hypothalamic-pituitary-adrenocortical (HPA) system is related to severity of benzodiazepine withdrawal in patients with depression.
Wichniak A; Brunner H; Ising M; Pedrosa Gil F; Holsboer F; Friess E
Psychoneuroendocrinology; 2004 Oct; 29(9):1101-8. PubMed ID: 15219633
[TBL] [Abstract][Full Text] [Related]
8. Relationships between psychological distress, coping styles, and HPA axis reactivity in healthy adults.
Hori H; Ozeki Y; Teraishi T; Matsuo J; Kawamoto Y; Kinoshita Y; Suto S; Terada S; Higuchi T; Kunugi H
J Psychiatr Res; 2010 Oct; 44(14):865-73. PubMed ID: 20334880
[TBL] [Abstract][Full Text] [Related]
9. Assessment of the dexamethasone/CRH test as a state-dependent marker for hypothalamic-pituitary-adrenal (HPA) axis abnormalities in major depressive episode: a Multicenter Study.
Kunugi H; Ida I; Owashi T; Kimura M; Inoue Y; Nakagawa S; Yabana T; Urushibara T; Kanai R; Aihara M; Yuuki N; Otsubo T; Oshima A; Kudo K; Inoue T; Kitaichi Y; Shirakawa O; Isogawa K; Nagayama H; Kamijima K; Nanko S; Kanba S; Higuchi T; Mikuni M
Neuropsychopharmacology; 2006 Jan; 31(1):212-20. PubMed ID: 16123748
[TBL] [Abstract][Full Text] [Related]
10. High neuroticism and depressive temperament are associated with dysfunctional regulation of the hypothalamic-pituitary-adrenocortical system in healthy volunteers.
Zobel A; Barkow K; Schulze-Rauschenbach S; Von Widdern O; Metten M; Pfeiffer U; Schnell S; Wagner M; Maier W
Acta Psychiatr Scand; 2004 May; 109(5):392-9. PubMed ID: 15049775
[TBL] [Abstract][Full Text] [Related]
11. Plasma corticosterone, dexamethasone (DEX) suppression and DEX/CRH tests in a rat model of genetic vulnerability to depression.
Steimer T; Python A; Schulz PE; Aubry JM
Psychoneuroendocrinology; 2007 Jun; 32(5):575-9. PubMed ID: 17512120
[TBL] [Abstract][Full Text] [Related]
12. Cortisol responses to combined dexamethasone/CRH test in outpatients with a major depressive episode.
Gervasoni N; Bertschy G; Osiek C; Perret G; Denis R; Golaz J; Rossier MF; Bondolfi G; Aubry JM
J Psychiatr Res; 2004; 38(6):553-7. PubMed ID: 15458850
[TBL] [Abstract][Full Text] [Related]
13. Differential frontal-striatal and paralimbic activity during reversal learning in major depressive disorder and obsessive-compulsive disorder.
Remijnse PL; Nielen MM; van Balkom AJ; Hendriks GJ; Hoogendijk WJ; Uylings HB; Veltman DJ
Psychol Med; 2009 Sep; 39(9):1503-18. PubMed ID: 19171077
[TBL] [Abstract][Full Text] [Related]
14. An investigation of hypothalamic-pituitary-adrenal axis hyperactivity in anorexia nervosa: the role of CRH and AVP.
Connan F; Lightman SL; Landau S; Wheeler M; Treasure J; Campbell IC
J Psychiatr Res; 2007; 41(1-2):131-43. PubMed ID: 16455105
[TBL] [Abstract][Full Text] [Related]
15. Combined dexamethasone/corticotropin-releasing hormone test in acute and remitted manic patients, in acute depression, and in normal controls: I.
Schmider J; Lammers CH; Gotthardt U; Dettling M; Holsboer F; Heuser IJ
Biol Psychiatry; 1995 Dec; 38(12):797-802. PubMed ID: 8750037
[TBL] [Abstract][Full Text] [Related]
16. Combined dexamethasone/corticotropin releasing hormone test predicts treatment response in major depression - a potential biomarker?
Ising M; Horstmann S; Kloiber S; Lucae S; Binder EB; Kern N; Künzel HE; Pfennig A; Uhr M; Holsboer F
Biol Psychiatry; 2007 Jul; 62(1):47-54. PubMed ID: 17123470
[TBL] [Abstract][Full Text] [Related]
17. Associations between cognitive performance and cortisol reaction to the DEX/CRH test in patients recovered from depression.
Behnken A; Bellingrath S; Symanczik JP; Rieck MJ; Zavorotnyy M; Domschke K; Arolt V; Zwanzger P
Psychoneuroendocrinology; 2013 Mar; 38(3):447-54. PubMed ID: 22840287
[TBL] [Abstract][Full Text] [Related]
18. Brain-derived neurotrophic factor Val66Met polymorphism and dexamethasone/CRH test results in depressed patients.
Schüle C; Zill P; Baghai TC; Eser D; Zwanzger P; Wenig N; Rupprecht R; Bondy B
Psychoneuroendocrinology; 2006 Sep; 31(8):1019-25. PubMed ID: 16890377
[TBL] [Abstract][Full Text] [Related]
19. Combined dexamethasone/corticotropin-releasing hormone test in patients with schizophrenia and in normal controls: II.
Lammers CH; Garcia-Borreguero D; Schmider J; Gotthardt U; Dettling M; Holsboer F; Heuser IJ
Biol Psychiatry; 1995 Dec; 38(12):803-7. PubMed ID: 8750038
[TBL] [Abstract][Full Text] [Related]
20. Combined dexamethasone/corticotropin-releasing factor test in chronic fatigue syndrome.
Van Den Eede F; Moorkens G; Hulstijn W; Van Houdenhove B; Cosyns P; Sabbe BG; Claes SJ
Psychol Med; 2008 Jul; 38(7):963-73. PubMed ID: 17803834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
